Read here for Tweedy Browne's latest 13F updates, top holdings like Ionis Pharma, and shifting investment strategies.
Zacks Investment Research on MSN
Vertex Pharmaceuticals (VRTX) dips more than broader market: What you should know
Vertex Pharmaceuticals (VRTX) closed at $453.74 in the latest trading session, marking a -1.31% move from the prior day. This change lagged the S&P 500's daily loss of 0.14%. Meanwhile, the Dow ...
Medical breakthroughs 2025 report highlights FDA approvals, gene therapies, and robotic telesurgery advancing patient care this year.
Palo Alto Networks will significantly expand the scope of the cybersecurity offerings it makes available on Google Cloud in the New Year while at the same ...
OctopusEffects, #Blender Instructions for creating a slice with a spark that splits the object in Blender 2.9. Detailed ...
Learn how we built a WordPress plugin that uses vectors and LLMs to manage semantic internal linking directly inside the ...
Microsoft in November launched a managed memory feature for its Foundry Agent Service, enabling enterprise AI agents to ...
As the United States market kicks off a holiday-shortened week with major stock indexes closing lower, investors are closely ...
Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the ...
According to Gartner, 58% of finance functions employed AI in 2024—a 21-percentage-point jump from the prior year. PwC ...
From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer’s disease, 2025 has been a ...
Royalty Pharma plc (Nasdaq: RPRX) today announced that it has acquired the final portion of PTC Therapeutics' remaining royalty on Roche's Evrysdi for $240 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results